Details for Patent: 11,141,540
✉ Email this page to a colleague
Which drugs does patent 11,141,540 protect, and when does it expire?
Patent 11,141,540 protects SYMJEPI and is included in one NDA.
This patent has thirty-two patent family members in seventeen countries.
Summary for Patent: 11,141,540
| Title: | Syringe devices |
| Abstract: | Described herein are syringe devices comprising a syringe including a therapeutic dose of at least one drug and a stopper. The syringe is housed and/or placed in an encasement. The plunger assembly can include a plunger, an actuator, and a spacer, wherein the plunger assembly is configured to move the stopper a predetermined distance without a user touching the plunger. Methods of assembling and using the syringe devices are also described. |
| Inventor(s): | Rolfs; Bryan E. (St. Paul, MN), Flather; Mark J. (San Diego, CA), Daniels; Karen K. (San Diego, CA), Moll; Thomas (San Diego, CA) |
| Assignee: | Adamis Pharmaceuticals Corporation (San Diego, CA) |
| Application Number: | 15/754,569 |
|
Patent Claim Types: see list of patent claims | Use; Compound; Delivery; Device; |
Drugs Protected by US Patent 11,141,540
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adamis Pharms Corp | SYMJEPI | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 207534-002 | Sep 27, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | A METHOD FOR ADMINISTERING A THERAPEUTIC DOSE OF EPINEPHRINE | ⤷ Sign Up | |||
| Adamis Pharms Corp | SYMJEPI | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 207534-001 | Jun 15, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | A METHOD FOR ADMINISTERING A THERAPEUTIC DOSE OF EPINEPHRINE | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 11,141,540
| PCT Information | |||
| PCT Filed | March 17, 2016 | PCT Application Number: | PCT/US2016/022956 |
| PCT Publication Date: | March 02, 2017 | PCT Publication Number: | WO2017/034618 |
International Family Members for US Patent 11,141,540
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2016313110 | ⤷ Sign Up | |||
| Australia | 2019203244 | ⤷ Sign Up | |||
| Australia | 2020202668 | ⤷ Sign Up | |||
| Australia | 2022202422 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
